Logo

Vol. 119, No. 6

May 31, 2009
On this page
Position paper of the Working Group of three Polish National Consultants in internal medicine, gastroenterology, and cardiology on prevention of gastrointestinal complications during antiplatelet treatment
Jacek Imiela, Grzegorz Opolski, Grażyna Rydzewska, Dorota Baczewska‑Mazurkiewicz, Robert Małecki, Krzysztof J. Filipiak
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 347–348; DOI: 10.20452/pamw.703
Lessons from the ACCOMPLISH trial
Joseph L. Izzo
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 344–346; DOI: 10.20452/pamw.701
Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l
Anetta Undas, Roman Topór‑Mądry, Wiesława Tracz
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 354–359; DOI: 10.20452/pamw.707
Noninvasive positive pressure ventilation Effect on mortality in acute cardiogenic pulmonary edema: a pragmatic meta‑analysis
Jayson Mathew Potts
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 349–353; DOI: 10.20452/pamw.705
Usefulness of classic cytogenetic testing compared to fluorescence in situ hybridization in genetic diagnosis of 58 patients with myelodysplastic syndromes
Katarzyna Skonieczka, Ewa Duszeńko, Elżbieta Wyrowińska, Olga Haus
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 366–372; DOI: 10.20452/pamw.711
Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control
Anetta Undas, Mariola Cieśla‑Dul, Marek Żółciński, Wiesława Tracz
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 360–365; DOI: 10.20452/pamw.709
Management of hypertension Evidence from the Blood Pressure Lowering Treatment Trialists’ Collaboration and from major clinical trials
John Chalmers, Hisatomi Arima
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 373–380; DOI: 10.20452/pamw.713
Coronary computed tomographic angiography: current role in the diagnosis and management of coronary artery disease
Andrew W. Bowman, Birgit Kantor, Thomas C. Gerber
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 381–390; DOI: 10.20452/pamw.715
Severe coronary artery disease Is there a place for percutaneous coronary intervention?
William R. Herzog, Andrew Farb
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 397–402; DOI: 10.20452/pamw.719
Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?
Alexander C. Ford, Paul Moayyedi
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 391–396; DOI: 10.20452/pamw.717
Therapeutic properties and safety of recombinant factor VIII and factor IX
Joanna Zdziarska, Krzysztof Chojnowski, Anna Klukowska, Magdalena Łętowska, Andrzej Mital, Maria Podolak‑Dawidziak, Jerzy Windyga, Krystyna Zawilska
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 403–409; DOI: 10.20452/pamw.721
Coexistence of two types of allergic hypersensitivity to drugs: case report
Joanna Glück, Barbara Rymarczyk, Barbara Rogala
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 418–421; DOI: 10.20452/pamw.723
Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells
Emilian Snarski, Tigran Torosian, Monika Paluszewska, Elżbieta Urbanowska, Alicja Milczarczyk, Krystyna Jedynasty, Edward Franek, Wiesław Wiktor Jędrzejczak
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 422–426; DOI: 10.20452/pamw.725
Catastrophic antiphospholipid syndrome
Agnieszka Furmańczyk, Ewa Komuda‑Leszek, Wioletta Gadomska, Jerzy Windyga, Magdalena Durlik
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 427–430; DOI: 10.20452/pamw.727
Yin and yang of the plasminogen activator inhibitor
Jerzy Jankun, Ewa Skrzypczak‑Jankun
Pol Arch Intern Med. 2009, Vol. 119, No. 6: 410–417; DOI: 10.20452/pamw.729